Haleon plc (FRA:H6D0)

Revenue by Geography

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
North America Revenue	3.94B	4.04B
EMEA & LatAm Revenue	4.52B	4.63B
APAC Revenue	2.56B	2.56B
Revenue (Total)	11.02B	11.23B

Revenue

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Oral Health Revenue	3.36B	3.31B
Vitamins, Minerals and Supplement Revenue	1.67B	1.70B
Pain Relief Revenue	2.55B	2.56B
Respiratory Health Revenue (Pre-Q2 2025 Reporting)	-	1.68B
Digestive Health and Other Revenue (Pre-Q2 2025 Reporting)	-	1.98B
Revenue (Other)	3.44B	-
Revenue (Total)	11.02B	11.23B

Adjusted EBIT by Geography

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
North America Adjusted Operating Profit	968.00M	1.00B
EMEA & LatAm Adjusted Operating Profit	1.01B	1.05B
APAC Adjusted Operating Profit	541.00M	539.00M
Corporate Adjusted Operating Profit	-70.00M	-93.00M
Operating Income (Other)	-192.00M	-294.00M
Operating Income (Total)	2.26B	2.21B

Key Performance Indicators

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Organic Revenue Growth	5.00%
Sales Growth due to Price	3.70%
Sales Growth due to Volume/Mix	1.30%

Updated Jun 30, 2025. Data Source: Fiscal.ai.